Food and Drug Administration's Regulation of Dietary Supplements: Hearing Before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Third Congress, First Session, July 20, 1993U.S. Government Printing Office, 1994 - 518페이지 Distributed to some depository libraries in microfiche. |
도서 본문에서
94개의 결과 중 1 - 5개
3 페이지
... manufacturers producing and selling misleading products to , often , the most vulnerable members of society , those that are very ill or uneducated . And so how you look at a balance for Americans who want to look at alternative ...
... manufacturers producing and selling misleading products to , often , the most vulnerable members of society , those that are very ill or uneducated . And so how you look at a balance for Americans who want to look at alternative ...
11 페이지
... manufacturing practice , section 502 ( a ) --drugs with false or misleading labeling , section 502 ( f ) ( 1 ) --products failing to bear adequate directions for use , section 503 -- prescription drugs dispensed without a prescription ...
... manufacturing practice , section 502 ( a ) --drugs with false or misleading labeling , section 502 ( f ) ( 1 ) --products failing to bear adequate directions for use , section 503 -- prescription drugs dispensed without a prescription ...
16 페이지
... manufacturer and suggested a role for some impurity or other compound in these batches of L- tryptophan in the etiology of EMS . However , both initial and subsequent epidemiological studies on the EMS epidemic have identified cases of ...
... manufacturer and suggested a role for some impurity or other compound in these batches of L- tryptophan in the etiology of EMS . However , both initial and subsequent epidemiological studies on the EMS epidemic have identified cases of ...
17 페이지
... manufacturers of these products submit any additional information that may be available on the safety and use of individual amino acids or combinations of amino acids as ingredients in dietary supplements . As discussed in the ANPR ...
... manufacturers of these products submit any additional information that may be available on the safety and use of individual amino acids or combinations of amino acids as ingredients in dietary supplements . As discussed in the ANPR ...
25 페이지
... manufacturer . If the Richardson legislation passes , the burden would be shifted to FDA to demonstrate that something is harmful . On the labeling side , you talked in your preliminary remarks about having FDA perform some kind of role ...
... manufacturer . If the Richardson legislation passes , the burden would be shifted to FDA to demonstrate that something is harmful . On the labeling side , you talked in your preliminary remarks about having FDA perform some kind of role ...
기타 출판본 - 모두 보기
자주 나오는 단어 및 구문
1990 amendments agency American amino acids antioxidants approved associated benefits beta-carotene botanical caffeine cancer cause Chairman chemical chronic claims for dietary clinical comfrey CONGRESS THE LIBRARY consumers consumption containing conventional food form Crotalaria diet dietary supplements doses Drug Administration effects epidemic evidence exposure FDA Regulation FDA's folic acid food additive Food and Drug health claims heart disease hepatic Hepatic veno-occlusive disease herbal products herbal tea herbs human Huxtable industry ingestion ingredients intake issue L-tryptophan levels LIBRARY OF CONGRESS liver manufacturers medicines monocrotaline neural tube defects NLEA nutrients nutrition labeling percent plant potential prevent Proposed Rules protect public health pyrrolizidine alkaloids pyrrolizidine poisoning recommendation Regulation of Dietary regulatory reported retrorsine safe safety Senecio significant scientific agreement Silverglade species standard studies Subcommittee substances supplement products Symphytum testimony toxicity veno-occlusive disease vitamin E vitamins and minerals women
인기 인용구
13 페이지 - food additive" means any substance the intended use of which results or may reasonably be expected to result, directly or indirectly, in its becoming a component or otherwise affecting the characteristics of any food...
118 페이지 - special dietary uses", as applied to food for man, means particular (as distinguished from general) uses of food, as follows: (1) Uses for supplying particular dietary needs which exist by reason of a physical, physiological, pathological or other condition, including but not limited to the conditions of...
100 페이지 - MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study.
305 페이지 - The glories of our blood and state Are shadows, not substantial things ; There is no armour against fate ; Death lays his icy hand on kings : Sceptre and crown Must tumble down, And in the dust be equal made With the poor crooked scythe and spade.
508 페이지 - The summary must establish that, based on the totality of publicly available scientific evidence (including evidence from well-designed studies conducted in a manner which is consistent with generally recognized scientific procedures and principles), there is significant scientific agreement among experts qualified by scientific training and experience to evaluate such claims, that the claim is supported by such evidence.
94 페이지 - All women of childbearing age in the United States who are capable of becoming pregnant should consume 0.4 mg of folic acid per day for the purpose of reducing their risk of having a pregnancy affected with spina bifid, i or other NTDs.
134 페이지 - If it purports to be or is represented for special dietary uses, unless its label bears such information concerning its vitamin, mineral, and other dietary properties as the Secretary determines to be, and by regulations prescribes as, necessary in order fully to inform purchasers as to its value for such uses.
393 페이지 - DEPARTMENT OF HEALTH AND HUMAN SERVICES BEFORE THE SUBCOMMITTEE ON HUMAN RESOURCES AND INTERGOVERNMENTAL RELATIONS COMMITTEE ON GOVERNMENT OPERATIONS US HOUSE OF REPRESENTATIVES JUNE 6.
498 페이지 - Two copies of any comments are to be submitted, except that individuals may submit one copy. Comments are to be identified with the docket number found in brackets in the heading of this document. Received comments may be seen in the office above between 9 am and 4 pm, Monday through Friday. Otis R. Bowen Secretary of Health and Human Services Dated : 1)1 r\l; I \\\ \l til 111 \ll HN HUMAN MR\ l...
100 페이지 - Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects.